Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Agranulocytosis clinical presentation

In preliminary clinical trials, 2 of 2,796 mirtazapine-treated patients developed agranulocytosis, and 1 developed severe neutropenia. All 3 patients recovered after medication discontinuation, and other possible etiologies were present in at least 1 of these individuals. Thirteen patients with pretreatment neutropenia did develop more severe neutropenia or agranulocytosis. Postmarketing evaluation to date has not established a causal relation between mirtazapine and agranulocytosis. Routine laboratory monitoring is not currently recommended. [Pg.40]

See other pages where Agranulocytosis clinical presentation is mentioned: [Pg.338]    [Pg.3389]    [Pg.123]    [Pg.53]    [Pg.141]    [Pg.85]    [Pg.141]    [Pg.291]    [Pg.460]   
See also in sourсe #XX -- [ Pg.1879 ]



SEARCH



Agranulocytosis

Clinical presentation

© 2024 chempedia.info